Sai Life Sciences

formerly Sai Advantium PharmaIPO

CRDMO Partner for Drug Discovery to Manufacturing | Sai Life

Public · Hyderabad, India · Founded 1999 · $135.0M raised

Headquarters
Hyderabad
Employees
1001–5000
Founded
1999
Business Model
B2B
Total Funding
$135.0M
Last Round
$135.0M Private EquityJan 2018
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Founded in 1999 as Sai Dru Syn Laboratories in Hyderabad, India, Sai Life Sciences grew from a small medicinal chemistry services provider into an integrated CRDMO serving pharmaceutical and biotechnology innovators worldwide. The company has expanded across discovery, development, and commercial manufacturing, with sites in Hyderabad, Bidar, Manchester (UK), and Greater Boston (US), and listed on India's NSE and BSE stock exchanges in 2024.

Summary

Sai Life Sciences is a Biotech company based in Hyderabad, India, founded in 1999. It has raised $135.0M in total across 2 rounds, most recently a $135.0M Private Equity round in Jan 2018. Investors include TPG (Growth/Rise) and Tata Capital Innovations Fund.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPODec 2024
$358.4M

Sign up to see all 4 events

Funding: Private Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sai Life Sciences on Indexed.vc
<a href="https://indexed.vc/companies/sai-life-sciences"><img src="https://indexed.vc/api/badge/company/sai-life-sciences" alt="Sai Life Sciences on Indexed.vc" width="260" height="76" /></a>